scholarly journals Cardiovascular Disease Associated with the Chronic Use of Ergotamine: A Case Report

2018 ◽  
Keyword(s):  
Cardiovascular Disease ◽  
Case Report ◽  
Chronic Use

scholarly journals Atypical femoral fracture due to chronic use of bisphosphonates: case report

2015 ◽  
Vol 50 (4) ◽  
pp. 482-485
Author(s):  
Eduardo Frois Temponi ◽  
Lúcio Honório de Carvalho Junior ◽  
Lincoln Paiva Costa
Keyword(s):  
Case Report ◽  
Femoral Fracture ◽  
Atypical Femoral Fracture ◽  
Chronic Use

ORAL MANIFESTATION OF THE CHRONIC USE OF SODIUM VALPROATE: A CASE REPORT

2020 ◽  
Vol 130 (3) ◽  
pp. e149
Author(s):  
GABRIELLA ALVES QUIXABEIRA OLIVEIRA ◽  
FERNANDA FERREIRA NUNES ◽  
DIEGO ANTONIO COSTA ARANTES ◽  
NÁDIA DO LAGO COSTA ◽  
NÁDIA APARECIDA BÉRGAMO ◽  
...  
Keyword(s):  
Case Report ◽  
Sodium Valproate ◽  
Oral Manifestation ◽  
Chronic Use

scholarly journals Giant Penile Lymphedema Caused by Chronic Penile Strangulation with Rubber Band: A Case Report and Review of the Literature

2018 ◽  
Vol 2018 ◽  
pp. 1-3
Author(s):  
Shunsuke Hori ◽  
Yozo Mitsui ◽  
Hidenori Iwai ◽  
Toshihiro Tai ◽  
Hideyuki Kobayashi ◽  
...  
Keyword(s):  
Urinary Incontinence ◽  
Case Report ◽  
Rubber Band ◽  
Review Of The Literature ◽  
Penile Skin ◽  
Penile Strangulation ◽  
Old Japanese ◽  
Seventh Report ◽  
Chronic Use

We treated a 65-year-old Japanese man with a giant penile lymphedema due to chronic penile strangulation with a rubber band. He was referred to our hospital with progressive penile swelling that had developed over a period of 2 years from chronic use of a rubber band placed around the penile base for prevention of urinary incontinence. Under a diagnosis of giant penile lymphedema, we performed resection of abnormal penile skin weighing 4.8 kg, followed by a penile plasty procedure. To the best of our knowledge, this is only the seventh report of such a case worldwide, with the present giant penile lymphedema the most reported.

scholarly journals Multifocal osteonecrosis secondary to occupational exposure to aluminum

2017 ◽  
Vol 25 (3) ◽  
pp. 103-106 ◽  
Author(s):  
Jorge Henrique Assunção ◽  
Eduardo Angeli Malavolta ◽  
Mauro Emilio Conforto Gracitelli ◽  
Renée Zon Filippi ◽  
Arnaldo Amado Ferreira Neto
Keyword(s):  
Renal Failure ◽  
Risk Factor ◽  
Case Report ◽  
Occupational Exposure ◽  
Aluminum Toxicity ◽  
Bone Lesions ◽  
Main Risk Factor ◽  
Level Of Evidence ◽  
Aluminum Level ◽  
Chronic Use

ABSTRACT Multifocal osteonecrosis is a rare disease; chronic use of corticosteroids is considered the main risk factor. Patients with chronic renal failure can develop aluminum toxicity, which can lead to osteomalacia and encephalopathy. An association between osteonecrosis and aluminum toxicity has been reported among patients with dialytic renal insufficiency. Occupational exposure to aluminum rarely causes lung disease and no cases of bone lesions resulting from exposure to this metal have been reported. In this manuscript, we describe a novel case of a patient with multifocal osteonecrosis associated with chronic occupational exposure to aluminum. Level of Evidence IV, Case Report.

Managing valproic acid toxicity-related hyperammonaemia: an unpredicted course

2021 ◽  
Vol 14 (4) ◽  
pp. e241547
Author(s):  
Sandeep Pagali ◽  
Christopher Edquist ◽  
Nicholas O'Rourke
Keyword(s):  
Valproic Acid ◽  
Case Report ◽  
First Case ◽  
Intermittent Haemodialysis ◽  
Symptom Relapse ◽  
Acid Toxicity ◽  
Chronic Use

A 20-year-old woman presented following an intentional overdose of valproic acid. Use of valproic acid, either acute or chronic, can result in hyperammonaemia. Mild hyperammonaemia with chronic use is mostly asymptomatic but can also present with concern for encephalopathy. Acute valproic acid toxicity results in significant hyperammonaemia, which can contribute to encephalopathy. Levocarnitine is the treatment of choice in valproic acid toxicity-related hyperammonaemia. For severe cases of encephalopathy, intermittent haemodialysis can also be considered. To our knowledge, this is the first case report to clearly show symptom relapse and hyperammonaemia after discontinuing levocarnitine. We recommend levocarnitine therapy for at least 72 hours, followed by an additional 24 hours of monitoring for symptom relapse and hyperammonaemia after levocarnitine discontinuation.

Atrial Fibrillation during Adjuvant Chemotherapy with Docetaxel: A Case Report

2002 ◽  
Vol 88 (6) ◽  
pp. 527-529 ◽  
Author(s):  
Marzia Palma ◽  
Andrea Mancuso ◽  
Federico Grifalchi ◽  
Antonio Lugini ◽  
Nicoletta Pizzardi ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Cardiovascular Disease ◽  
Clinical Trials ◽  
Case Report ◽  
Adjuvant Chemotherapy ◽  
Thyroid Dysfunction ◽  
Ductal Carcinoma ◽  
Controlled Clinical Trials ◽  
Carcinoma Of The Breast ◽  
Infiltrating Ductal Carcinoma

A 46-year-old woman had an episode of atrial fibrillation during infusion of docetaxel as adjuvant chemotherapy for an infiltrating ductal carcinoma of the breast. All cardiological tests performed before treatment were normal and there was no evidence of thyroid dysfunction nor any objective or anamnestic data indicating acute or chronic cardiovascular disease. None of the drugs administered has ever shown any proarrhythmic activity. In controlled clinical trials docetaxel was found to have a very low cardiotoxicity.

scholarly journals Crutch-related acute arterial thrombosis in upper limb: case report

2014 ◽  
Vol 13 (4) ◽  
pp. 340-344 ◽  
Author(s):  
Maurício dos Reis Basílio ◽  
Alex Aparecido Cantador ◽  
Giovani José Dal Poggetto Molinari ◽  
Fábio Hüsemann Menezes
Keyword(s):  
Case Report ◽  
Upper Limb ◽  
Arterial Thrombosis ◽  
Axillary Artery ◽  
Review Of The Literature ◽  
Chronic Use

Case report of an acute arterial obstruction in the upper limb secondary to thrombosis of the axillary artery caused by chronic use of crutches. The authors make a brief review of the literature and discuss it in relation to the present case.

Sign in / Sign up

Export Citation Format

Share Document